Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Other 1

Conditions

CIPN 1

Interventions

Tirzepatide 2Exercise 2Bariatric Surgery 2semaglutide 1mirogabalin 1exemestane 1Standard of Care 1Sex Education 1Resistance Training 1Progestins 1Patient Navigation 1Oxycodone 1Nutrition Assessment 1Mindfulness 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Low-Level Light Therapy 1Leuprolide 1Letrozole 1Hysteroscopy 1Hepatectomy 1Goserelin 1Gonadotropin-Releasing Hormone 1Fecal Microbiota Transplantation 1Estrogen Replacement Therapy 1Duloxetine Hydrochloride 1Diet Therapy 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Duloxetine Hydrochloride × Other × Clear all
NCT06711978 2024-12-02

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

Pusan National University Yangsan Hospital

Phase NA Not yet recruiting
66 enrolled
BreastOther

CIPN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡